-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
StockNews.com Initiates Coverage on Jaguar Health (NASDAQ:JAGX)
StockNews.com Initiates Coverage on Jaguar Health (NASDAQ:JAGX)
StockNews.com started coverage on shares of Jaguar Health (NASDAQ:JAGX – Get Rating) in a report released on Monday. The brokerage set a "hold" rating on the biotechnology company's stock.
Jaguar Health Stock Down 2.9 %
Shares of JAGX stock opened at $0.16 on Monday. The stock has a market cap of $18.73 million, a P/E ratio of -0.14 and a beta of 1.65. Jaguar Health has a one year low of $0.15 and a one year high of $2.66. The stock has a fifty day moving average price of $0.24 and a 200 day moving average price of $0.36. The company has a debt-to-equity ratio of 8.47, a current ratio of 1.02 and a quick ratio of 0.73.
Get Jaguar Health alerts:Jaguar Health (NASDAQ:JAGX – Get Rating) last issued its earnings results on Monday, August 22nd. The biotechnology company reported ($0.12) EPS for the quarter, topping the consensus estimate of ($0.22) by $0.10. The firm had revenue of $2.92 million during the quarter. Jaguar Health had a negative return on equity of 486.62% and a negative net margin of 652.35%. Analysts predict that Jaguar Health will post -0.67 earnings per share for the current year.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently bought and sold shares of the company. Citigroup Inc. bought a new position in shares of Jaguar Health during the first quarter valued at $34,000. Goldman Sachs Group Inc. lifted its holdings in shares of Jaguar Health by 153.3% during the first quarter. Goldman Sachs Group Inc. now owns 54,770 shares of the biotechnology company's stock valued at $39,000 after acquiring an additional 33,148 shares during the period. Bank of New York Mellon Corp lifted its holdings in shares of Jaguar Health by 507.3% during the first quarter. Bank of New York Mellon Corp now owns 169,749 shares of the biotechnology company's stock valued at $120,000 after acquiring an additional 141,796 shares during the period. Millennium Management LLC lifted its holdings in shares of Jaguar Health by 152.3% during the second quarter. Millennium Management LLC now owns 533,153 shares of the biotechnology company's stock valued at $157,000 after acquiring an additional 321,795 shares during the period. Finally, Virtu Financial LLC lifted its holdings in shares of Jaguar Health by 76.1% during the first quarter. Virtu Financial LLC now owns 229,270 shares of the biotechnology company's stock valued at $162,000 after acquiring an additional 99,073 shares during the period. 7.40% of the stock is owned by institutional investors.About Jaguar Health
(Get Rating)
Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.
Recommended Stories
- Get a free copy of the StockNews.com research report on Jaguar Health (JAGX)
- Archer Daniels Midland: Dividend Hero With 49 Years Of Increases
- Will Fully Autonomous Tractors Make Deere the Tesla of Farming?
- Magna International is Your Auto and EV One-Stop Shop Stock
- EV Battery Maker Freyr Set For Major Global Expansion
- MarketBeat: Week in Review 9/26 – 9/30
Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with MarketBeat.com's FREE daily email newsletter.
StockNews.com started coverage on shares of Jaguar Health (NASDAQ:JAGX – Get Rating) in a report released on Monday. The brokerage set a "hold" rating on the biotechnology company's stock.
斯托克新闻网在周一发布的一份报告中开始对捷豹健康(纳斯达克：JAGX-GET评级)的股票进行报道。该经纪公司对这家生物技术公司的股票设定了“持有”评级。
Jaguar Health Stock Down 2.9 %
捷豹健康类股下跌2.9%
Shares of JAGX stock opened at $0.16 on Monday. The stock has a market cap of $18.73 million, a P/E ratio of -0.14 and a beta of 1.65. Jaguar Health has a one year low of $0.15 and a one year high of $2.66. The stock has a fifty day moving average price of $0.24 and a 200 day moving average price of $0.36. The company has a debt-to-equity ratio of 8.47, a current ratio of 1.02 and a quick ratio of 0.73.
JAGX股票周一开盘报0.16美元。该股市值为1873万美元，市盈率为-0.14，贝塔系数为1.65。捷豹健康的一年低点为0.15美元，一年高位为2.66美元。该股的50日移动均价为0.24美元，200日移动均价为0.36美元。该公司的债务权益比为8.47，流动比率为1.02，速动比率为0.73。
Jaguar Health (NASDAQ:JAGX – Get Rating) last issued its earnings results on Monday, August 22nd. The biotechnology company reported ($0.12) EPS for the quarter, topping the consensus estimate of ($0.22) by $0.10. The firm had revenue of $2.92 million during the quarter. Jaguar Health had a negative return on equity of 486.62% and a negative net margin of 652.35%. Analysts predict that Jaguar Health will post -0.67 earnings per share for the current year.
捷豹健康(纳斯达克代码：JAGX-GET Rating)最近一次发布财报是在8月22日星期一。这家生物技术公司公布了本季度每股收益(0.12美元)，比普遍预期的(0.22美元)高出0.10美元。该公司本季度的收入为292万美元。捷豹健康的净资产回报率为负486.62%，净利润率为负652.35%。分析人士预测，捷豹健康今年的每股收益将为0.67美元。
Institutional Inflows and Outflows
机构资金流入和流出
About Jaguar Health
关于捷豹健康
(Get Rating)
(获取评级)
Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.
捷豹健康公司是一家商业阶段的制药公司，专注于为患有胃肠道不适的人和动物开发处方药，特别是慢性和衰弱的腹泻。该公司通过两个部门运营，人类健康和动物健康。它销售Mytesi，用于对患有艾滋病毒/艾滋病的成年人进行抗逆转录病毒治疗的非感染性腹泻的症状缓解。
Recommended Stories
推荐故事
- Get a free copy of the StockNews.com research report on Jaguar Health (JAGX)
- Archer Daniels Midland: Dividend Hero With 49 Years Of Increases
- Will Fully Autonomous Tractors Make Deere the Tesla of Farming?
- Magna International is Your Auto and EV One-Stop Shop Stock
- EV Battery Maker Freyr Set For Major Global Expansion
- MarketBeat: Week in Review 9/26 – 9/30
- 免费获取StockNews.com关于捷豹健康的研究报告(JAGX)
- 阿彻·丹尼尔斯·米德兰：49年增长的红利英雄
- 全自动拖拉机会让迪尔成为农业领域的特斯拉吗？
- 麦格纳国际是您的汽车和电动汽车一站式库存
- 电动汽车电池制造商Freyr将在全球大举扩张
- MarketBeat：回顾一周9/26-9/30
Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with MarketBeat.com's FREE daily email newsletter.
接受捷豹健康日报的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对捷豹健康和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧